SAN ANTONIO, Texas. (Ivanhoe Newswire) — For people who have multiple health conditions, fixing one can sometimes lead to problems with the other. Now, there is a new technology called DyeVert, which precisely controls and measures the amount of dye used in heart catheterizations and other procedures requiring imaging. For some patients, the dye itself can be toxic if the kidneys can’t flush it out of the system.
“I love her. She’s the best mother. I wouldn’t want any other,” Vincent Bowlin explained to Ivanhoe.
Vincent Bowlin, father of three with one on the way, is very concerned about his mom, Mary, who’s undergoing a heart catheterization. Mary is also diabetic. Her kidneys don’t function fully, making the procedure, which uses contrast dye, a risky one.
“When someone needs multiple procedures, one after another, each procedure puts them at risk for furthering kidney damage. And so if we can save the contrast dye at each step, we can then prevent a worse outcome in terms of her kidneys,” Anand Prasad, MD, FACC, FSCAI, RPVI, Associate Professor of Medicine at UT Health Science Center at San Antonio, Interventional Cardiologist at University Hospital stated. (Read Full Interview)
Doctor Prasad was the first in the U.S. to use DyeVert Plus, which precisely measures the right amount of contrast dye.
Doctor Prasad explained, “The dye itself is toxic to the kidneys and when someone has impaired renal function, they don’t excrete the dye like they should, so it sits there causing more and more damage.”
DyeVert uses Bluetooth wireless signals to give doctors real-time tracking of contrast dye, so patients aren’t getting any more than they really need. Mary loves her six grandchildren, wants to keep up with them, but with her trademark sense of humor says, right now; it’s good to be able to hand them back to mom and dad.
Mary said to Ivanhoe, “You can take care of them for a little bit, but once they get out of hand … Ok bye!”
DyeVert Plus, made by Osprey Medical, received FDA clearance earlier this year. The system is now being used at hospitals across the country.
Contributors to this news report include: Donna Parker, Field Producer; Bruce Maniscalco, Videographer; Cyndy McGrath, Supervising Producer; Gabriella Battistiol, Assistant Producer; Roque Correa, Editor.
To receive a free weekly e-mail on Medical Breakthroughs from Ivanhoe, sign up at: http://www.ivanhoe.com/ftk
TOPIC: DYEVERT PLUS: MAKING IMAGING SAFER!
REPORT: MB #4310
BACKGROUND: In a heart catheterization or a cardiac catheterization, a doctor puts a small, flexible, hollow tube, referred to as a catheter, into a blood vessel in the arm, neck or groin. This is threaded through the blood vessel into the aorta and finally into the heart. Once in place, several tests may be done. The doctor can place the tip of the catheter into different areas of the heart to measure pressures in the heart chambers, or take blood samples and to measure oxygen levels. The doctor may guide the catheter into the coronary arteries and inject contrast dye to check the blood flow through them. This is called coronary angiography.
COMPLICATIONS: Possible risks of complications include pain, bleeding or bruising where the catheter was inserted, blood clots or damage to the blood vessel where the catheter was inserted, infection around the site and problems with heart rhythm (usually temporary). More serious, rare complications include ischemia or decrease in blood flow to the heart which may result in chest pains and even a heart attack. Sudden blockage of the coronary artery, a tear in the lining of the artery, stroke, and finally possible kidney damage from the dye used during the procedure are also possible. This risk of kidney failure as a result of the dye is especially high for those with poor or low kidney function.
NEW TECHNOLOGY: DyeVert Plus is a new technology which regulates the amount of contrast dye doctors give to a patient during heart catheterizations and other procedures which require imaging. DyeVert Plus uses Bluetooth wireless signals to give doctors real-time tracking of contrast dye so patients aren’t getting any more than they really need. This can prevent the risk of the kidneys having a toxic reaction to too much dye if they have impaired function and aren’t able to properly excrete it as they should. DyeVert Plus was created by Osprey Medical and received FDA approval earlier this year. The system is now being used in hospitals across the country.
(Source: Anand Prasad, MD)
FOR MORE INFORMATION ON THIS REPORT, PLEASE CONTACT:
If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Marjorie Bekaert Thomas at email@example.com